OnKure Historical Balance Sheet
| OKUR Stock | 8.38 0.33 4.10% |
Trend analysis of OnKure Therapeutics, balance sheet accounts such as Accounts Payable of 3.3 M provides information on OnKure Therapeutics,'s total assets, liabilities, and equity, which is the actual value of OnKure Therapeutics, to its prevalent stockholders. By breaking down trends over time using OnKure Therapeutics, balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
OnKure |
About OnKure Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of OnKure Therapeutics, at a specified time, usually calculated after every quarter, six months, or one year. OnKure Therapeutics, Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of OnKure Therapeutics, and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which OnKure currently owns. An asset can also be divided into two categories, current and non-current.
OnKure Therapeutics, Balance Sheet Chart
Add Fundamental
Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Accounts Payable
An accounting item on the balance sheet that represents OnKure Therapeutics, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of OnKure Therapeutics, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Capital Lease Obligations
OnKure Therapeutics, capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to OnKure Therapeutics, asset purchases. For example, OnKure Therapeutics, can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as OnKure Therapeutics, control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Most accounts from OnKure Therapeutics,'s balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into OnKure Therapeutics, current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OnKure Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in OnKure Stock, please use our How to Invest in OnKure Therapeutics, guide.
| 2010 | 2023 | 2024 (projected) | Total Current Liabilities | 5.5M | 7.3M | 7.1M | Total Assets | 16.0M | 35.7M | 28.5M |
OnKure Therapeutics, balance sheet Correlations
Click cells to compare fundamentals
OnKure Therapeutics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with OnKure Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
| 0.76 | EVLO | Evelo Biosciences | PairCorr |
| 0.72 | VAXX | Vaxxinity | PairCorr |
| 0.67 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.66 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.59 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to OnKure Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics, to buy it.
The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.